Question from Deputy Ken O'Flynn - PQ 15815-26
Deputy O'Flynn asked about the full health technology assessment of tirzepatide for type 2 diabetes. Read the HSE response.
- Published date:
- :
Browse and read HSE's latest publications, which include strategic plans, reports, official policies and codes, Parliamentary Question (PQ) responses, and board meeting minutes.
Deputy O'Flynn asked about the full health technology assessment of tirzepatide for type 2 diabetes. Read the HSE response.
Deputy O'Flynn asked about the health technology assessments conducted in respect of tirzepatide. Read the HSE response.
Deputy O'Flynn asked about comparative reports detailing recruitment clearance timelines and vacancy duration. Read the HSE response.
Deputy O'Flynn asked about the recruitment autonomy of the 6 health regions. Read the HSE response.
Deputy O'Flynn asked about the gross and net weekly income thresholds applicable to applicants aged 70 years and over for a medical card. Read the HSE response.
Deputy O'Flynn asked about the Level 9 Social Work apprenticeship programme. Read the HSE response.
Deputy O'Flynn asked about the the formal methodology used when evaluating international clinical guidance. Read the HSE response.
Deputy O'Flynn asked whether any clinical risk assessment, patient safety review, or governance audit has been undertaken on gender healthcare services.
Deputy O'Flynn asked about the reimbursement of tirzepatide for weight management. Read the HSE response.
Deputy O'Flynn asked about gross expenditure incurred by the HSE in respect of apprenticeship programmes in social work, social care work, and dietetics.